Organon & Co. Files 8-K on Shareholder Vote Matters

TL;DR

Organon & Co. had a shareholder vote on June 4th, filed an 8-K on June 6th.

AI Summary

Organon & Co. filed an 8-K on June 6, 2024, reporting on matters submitted to a vote of security holders on June 4, 2024. The filing details the company's principal executive offices located at 30 Hudson Street, Floor 33, Jersey City, NJ 07302, and its telephone number is (551) 430-6900.

Why It Matters

This filing indicates that Organon & Co. held a vote of its security holders, which is a standard corporate governance event that shareholders should be aware of.

Risk Assessment

Risk Level: low — This is a routine corporate filing related to a shareholder vote, not indicating any immediate financial or operational risks.

Key Players & Entities

• Organon & Co. (company) — Registrant
• June 4, 2024 (date) — Date of earliest event reported
• June 6, 2024 (date) — Date of report
• 30 Hudson Street, Floor 33, Jersey City, NJ 07302 (location) — Principal executive offices
• (551) 430-6900 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share OGN NYSE Indicate by ch

Filing Documents

• tm2416592d1_8k.htm (8-K) — 39KB
• 0001104659-24-068876.txt ( ) — 209KB
• ogn-20240604.xsd (EX-101.SCH) — 3KB
• ogn-20240604_lab.xml (EX-101.LAB) — 33KB
• ogn-20240604_pre.xml (EX-101.PRE) — 22KB
• tm2416592d1_8k_htm.xml (XML) — 4KB

07

Item 5.07 Submission of Matters to a Vote of Security Holders. On June 4, 2024, Organon & Co. (the " Company ") held its 2024 Annual Meeting, at which the Company's shareholders considered three (3) proposals, each of which is described in more detail in the Company's proxy statement filed with the U.S. Securities and Exchange Commission on April 25, 2024 (the " Proxy Statement "). There were 257,172,661 outstanding shares entitled to vote and there were 221,544,166 shares present in person or by proxy at the 2024 Annual Meeting, representing approximately eighty-six percent (86%) of the shares outstanding and entitled to vote. The voting results are presented below. 1. To elect the four (4) Class III directors nominated by the Company's Board of Directors to serve until the 2025 annual meeting of Organon's shareholders or until a successor has been duly elected and qualified. Nominee For Against Abstain Broker Non-Votes 1 Kevin Ali 176,343,603 2,212,837 354,540 42,633,186 Martha E. McGarry 173,247,544 5,347,655 315,781 42,633,186 Philip Ozuah, M.D., Ph.D. 174,355,642 4,214,516 340,822 42,633,186 Shalini Sharp 176,315,828 2,258,415 336,737 42,633,186 2. To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. For Against Abstain Broker Non-Votes 1 149,712,445 28,201,528 997,007 42,633,186 3. To ratify the appointment by the Company's Audit Committee of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. For Against Abstain Broker Non-Votes 1 219,810,374 966,483 767,309 0 1 A broker-non vote occurs when a broker, bank, or other nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have the discretionary voting power with respect to the item and has not received voting instructions

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Organon & Co. By: /s/ Kirke Weaver Name: Kirke Weaver Title: General Counsel and Corporate Secretary Dated: June 6, 2024

View Full Filing

View this 8-K filing on SEC EDGAR